Lijuan Luan

A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation

Lijuan Luan, Yuguo Liu, Lijuan Luan · OncoTargets and Therapy · 2015 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of Borneol on the Distribution of Danshensu to the Eye in Rabbit via Oral Administration

Zhijian Li, Dianjun Sun, Hongbin Yang et al. · Current Eye Research · 2010 · 17 citations

Medicine, Ophthalmology, Pharmacology +16

The role of GPR110 in lung cancer progression

Benting Ma, Junjie Zhu, Jieakesu Su et al. · Annals of Translational Medicine · 2020 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +14

Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment

Weijie Chen, Huimei Wang, Dongxian Jiang et al. · World Journal of Surgical Oncology · 2021 · 12 citations · Full text

Veterinary Medicine, Oncology, Pathology +17

HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer

Yalan Liu, Lingli Chen, Dongxian Jiang et al. · Pathology - Research and Practice · 2021 · 12 citations

Medicine, Cell Biology, Oncology +13